The absorption on an empty stomach is minimal.
No information is present at this moment.
No information is present at this moment.
| Enterobiasis |
|---|
|
| Ascariasis, trichuriasis, toxocariasis and hookworm infections |
|---|
|
| Taenia Solium infection |
|---|
|
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Very rare: in infants: fever, convulsions and erythema multiforme.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
There is little experience of use in children younger than 2 years.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Benzimidazole derivatives | ||
|---|---|---|
| P02CA03 | ||
| Tetrahydropyrimidine derivatives | ||
|---|---|---|
| P02CC01 | ||
| Imidazothiazole derivatives | ||
|---|---|---|
| P02CE01 | ||
| Avermectines | ||
|---|---|---|
| P02CF01 | ||